New understanding of glucocorticoid action in bone cells

키워드

참고문헌 (57)

1. Manolagas, S. C., "New developments in the pathogenesis and treatment of steroid-induced osteoporosis", J. Bone Miner Res., 14, pp.1061~1066 (1999)
2. Weinstein, R. S., "Glucocorticoid-induced osteoporosis", Rev. Endocr. Metab. Disord., 2, pp.65~73 (2001)
3. Lukert, B. P., "Glucocorticoid-induced osteoporosis: pathogenesis and management", Ann. Intern. Med., 112, pp.352~364 (1990)
4. Canalis, E., "Perspectives on glucocorticoid-induced osteoporosis", Bone, 34, pp.593~598 (2004)
5. Luengo, M., "Intestinal calcium absorption and parathyroid hormone secretion in asthmatic patients on prolonged oral or inhaled steroid treatment", Eur. Respir. J., 4, pp.441~444 (1991)
6. Paz-Pacheco, E., "Intact parathyroid hormone levels are not elevated in glucocorticoid-treated subjects", J. Bone Miner Res., 10, pp.1713~1718 (1995)
7. Hollenberg, S. M., "Primary structure and expression of a functional human glucocorticoid receptor cDNA", Nature, 318, pp.635~641 (1985)
8. Miesfeld, R., "Characterization of a steroid hormone receptor gene and mRNA in wildtype and mutant cells", Nature, 312, pp.779~781 (1984)
9. Kumar, R., "Gene regulation by the glucocorticoid receptor: structure: function relationship", J. Steroid. Biochem. Mol. Biol., 94, pp.383~394 (2005)
10. Reichardt, H. M., "Glucocorticoid signalling--multiple variations of a common theme", Mol. Cell Endocrinol., 146, pp.1~6 (1998)
11. Ruppert, S., "Two genetically defined transacting loci coordinately regulate overlapping sets of liver-specific genes", Cell, 61, pp.895~904 (1990)
12. Drouin, J., "Novel glucocorticoid receptor complex with DNA element of the hormone-repressed POMC gene", EMBO J., 12, pp.145~156 (1993)
13. Stromstedt, P. E., "The glucocorticoid receptor binds to a sequence overlapping the TATA box of the human osteocalcin promoter: a potential mechanism for negative regulation", Mol. Cell Biol., 11, pp.3379~3383 (1991)
14. Li, C., "Glucocorticoid repression of human with-no-lysine (K) kinase-4 gene expression is mediated by the negative response elements in the promoter", J. Mol. Endocrinol., 40, pp.3~12 (2008)
15. Liberman, A. C., "Glucocorticoids in the regulation of transcription factors that control cytokine synthesis", Cytokine Growth Factor Rev., 18, pp.45~56 (2007)
16. Liberman, A. C., "Glucocorticoids inhibit GATA-3 phosphorylation and activity in T cells", FASEB J., 23, pp.1558~1571 (2009)
17. Liberman, A. C., "The activated glucocorticoid receptor inhibits the transcription factor T-bet by direct protein-protein interaction", FASEB J., 21, pp.1177~1188 (2007)
18. Ogawa, S., "Molecular determinants of crosstalk between nuclear receptors and toll-like receptors", Cell, 122, pp.707~721 (2005)
19. Weinstein, R. S., "Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone", J. Clin. Invest., 102, pp.274~282 (1998)
20. Espina, B., "Regulation of bim in glucocorticoid-mediated osteoblast apoptosis", J. Cell Physiol., 215, pp.488~496 (2008)
21. Kogianni, G., "Fas", CD95 is associated with glucocorticoid-induced osteocyte apoptosis, 2004, pp.75, 2879~2895
22. Liu, Y., "Basic helix-loop-helix proteins bind to TrkB and p21(Cip1) promoters linking differentiation and cell cycle arrest in neuroblastoma cells", Mol. Cell Biol., 24, pp.2662~2672 (2004)
23. O'Brien, C. A., "Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength", Endocrinology, 145, pp.1835~1841 (2004)
24. Smith, E., "Gluco corticoids inhibit cell cycle progression in differentiating osteoblasts via glycogen synthase kinase-3beta", J. Biol. Chem., 277, pp.18191~18197 (2002)
25. Canalis, E., "Clinical review 83: mechanisms of glucocorticoid action in bone: implications to glucocorticoid-induced osteoporosis", J. Clin. Endocrinol. Metab., 81, pp.3441~3447 (1996)
26. Pereira, R. C., "Effects of cortisol and bone morphogenetic protein-2 on stromal cell differentiation: correlation with CCAAT-enhancer binding protein expression", Bone, 30, pp.685~691 (2002)
27. Pereira, R. M., "Cortisol inhibits the differentiation and apoptosis of osteoblasts in culture", Bone, 28, pp.484~490 (2001)
28. Ito, S., "Glucocorticoids induce the differentiation of a mesenchymal progenitor cell line, ROB-C26 into adipocytes and osteoblasts, but fail to induce terminal osteoblast differentiation", Bone, 40, pp.84~92 (2007)
29. Pereira, R. C., "CCAAT", enhancer binding protein homologous protein (DDIT3) induces osteoblastic cell differentiation, 2004, pp.145, 1952~1960
30. Wu, Z., "Induction of peroxisome proliferator-activated receptor gamma during the conversion of 3T3 fibroblasts into adipocytes is mediated by C", EBPbeta, C, Mol. Cell Biol., pp.1996, 16[DOI]
31. Aubin, J. E., "Osteoprogenitor cell frequency in rat bone marrow stromal populations: role for heterotypic cell-cell interactions in osteoblast differentiation", J. Cell Biochem., 72, pp.396~410 (1999)
32. Eijken, M., "The essential role of glucocorticoids for proper human osteoblast differentiation and matrix mineralization", Mol. Cell Endocrinol., 248, pp.87~93 (2006)
33. Purpura, K. A., "Sustained in vitro expansion of bone progenitors is cell density dependent", Stem Cells, 22, pp.39~50 (2004)
34. Teitelbaum, S. L., "Bone resorption by osteoclasts", Science, 289, pp.1504~1508 (2000)
35. Hofbauer, L. C., "Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocorticoid-induced osteoporosis", Endocrinology, 140, pp.4382~4389 (1999)
36. Rubin, J., "Dexamethasone promotes expression of membrane-bound macrophage colony-stimulating factor in murine osteoblast-like cells", Endocrinology, 139, pp.1006~1012 (1998)
37. Dempster, D. W., "Bone histomorphometry in glucocorticoid-induced osteoporosis", J. Bone Miner Res., 4, pp.137~141 (1989)
38. Prummel, M. F., "The course of biochemical parameters of bone turnover during treatment with corticosteroids", J. Clin. Endocrinol. Metab., 72, pp.382~386 (1991)
39. Yong Hee Kim, "Dexamethasone Inhibits the Formation of Multinucleated Osteoclasts via Down-regulation of β3 Integrin Expression", Archives of Pharmacal Research, 29(8), pp.691~698 (2006), 대한약학회
40. Kim, H. J., "Glucocorticoids suppress bone formation via the osteoclast", J. Clin. Invest., 116, pp.2152~2160 (2006)
41. Jia, D., "Glucocorticoids act directly on osteoclasts to increase their life span and reduce bone density", Endocrinology, 147, pp.5592~5599 (2006)
42. Weinstein, R. S., "Promotion of osteoclast survival and antagonism of bisphosphonate-induced osteoclast apoptosis by glucocorticoids", J. Clin. Invest., 109, pp.1041~1048 (2002)
43. Teitelbaum, S. L., "Osteoclasts: what do they do and how do they do it?", Am. J. Pathol., 170, pp.427~435 (2007)
44. Teitelbaum, S. L., "Genetic regulation of osteoclast development and function", Nat. Rev. Genet., 4, pp.638~649 (2003)
45. Faccio, R., "Dynamic changes in the osteoclast cytoskeleton in response to growth factors and cell attachment are controlled by beta3 integrin", J. Cell Biol., 162, pp.499~509 (2003)
46. Nakamura, I., "IL-1 regulates cytoskeletal organization in osteoclasts via TNF receptor-associated factor 6", c-Src complex, 2002, pp.168, 5103~5109
47. Sakai, H., "Activated c-Fms recruits Vav and Rac during CSF-1-induced cytoskeletal remodeling and spreading in osteoclasts", Bone, 39, pp.1290~1301 (2006)
48. Ory, S., "Rho GTPases in osteoclasts: orchestrators of podosome arrangement", Eur. J. Cell Biol., 87, pp.469~477 (2008)
49. Chellaiah, M. A., "Rho-A is critical for osteoclast podosome organization, motility, and bone resorption", J. Biol. Chem., 275, pp.11993~12002 (2000)
50. Wang, Y., "Identifying the relative contributions of Rac1 and Rac2 to osteoclastogenesis", J. Bone Miner Res., 23, pp.260~270 (2008)
51. Etienne-Manneville, S., "Rho GTPases in cell biology", Nature, 420, pp.629~635 (2002)
52. Hornstein, I., "Vav proteins, masters of the world of cytoskeleton organization", Cell Signal, 16, pp.1~11 (2004)
53. Rossman, K. L., "GEF means go: turning on RHO GTPases with guanine nucleotide-exchange factors", Nat. Rev. Mol. Cell Biol., 6, pp.167~180 (2005)
54. Faccio, R., "Vav3 regulates osteoclast function and bone mass", Nat. Med., 11, pp.284~290 (2005)
55. Patschan, D., "Molecular mechanisms of glucocorticoid-induced osteoporosis", Bone, 29, pp.498~505 (2001)
56. Destaing, O., "A novel Rho-mDia2-HDAC6 pathway controls podosome patterning through microtubule acetylation in osteoclasts", J. Cell Sci., 118, pp.2901~2911 (2005)
57. Okumura, S., "Coordination of microtubules and the actin cytoskeleton is important in osteoclast function, but calcitonin disrupts sealing zones without affecting microtubule networks", Bone, 39, pp.684~693 (2006)

관련 논문AI추천